Evidence map›Paper›PMID 21667045›Full record

ArticleImmunogenetics2011

Expansion and diversification of the signaling capabilities of the CD2/SLAM family in Xenopodinae amphibians.

Sergey V Guselnikov, Petr P Laktionov, Alexander M Najakshin, Konstantin O Baranov, Alexander V Taranin

Abstract read
PubMed Publisher
In one paragraph

Article in Immunogenetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. The chicken SLAM family.Immunogenetics · 2013
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sergey V GuselnikovLaboratory of Immunogenetics, Department of Molecular and Cellular Biology, Institute of Chemical Biology and Fundamental Medicine, Prospekt Lavrentyeva 8, Novosibirsk, 630090, Russia. sguselnikov@mcb.nsc.ru
Petr P Laktionov
Alexander M Najakshin
Konstantin O Baranov
Alexander V Taranin
Institute of Chemical Biology and Fundamental Medicine · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We studied the evolution of the CD2 family in tetrapods by extracting and analyzing CD2-like genes from the genome of the amphibian species Silurana (Xenopus) tropicalis. An exhaustive analysis of the genomic and cDNA databases resulted in the identification of at least 70 CD2-like genes. The predicted receptors mostly maintain the typical VC2 ectodomains, but are highly diverse in their C-termini, which suggests a broad range of signaling capacities. Apart from the presumed monomeric receptors with ITSM and/or ITIM motifs, the Silurana family includes secreted proteins. Furthermore, a fraction of the receptors contain a conserved TM subtype with the NxxR motif that is known to promote an association with the FcRγ subunit and that was previously found in the members of the FcR- and KIR-related receptors. The expression analysis of a sample of the genes showed broad tissue distribution and gene-specific expression patterns. Phylogenetic analysis predicted that the CD58, CD150/SLAM, and SLAMF8 genes were maintained as single-copy genes in both mammals and amphibians, while others expanded/contracted in a lineage-specific manner.

Indexed as

Amino Acid SequenceAnimalsAntigens, CDCD2 AntigensEvolution, MolecularMolecular Sequence DataPhylogenyReceptors, Cell SurfaceSequence AlignmentSignaling Lymphocytic Activation Molecule Family Member 1Signal TransductionXenopusAntigens, CDCD2 AntigensReceptors, Cell SurfaceSignaling Lymphocytic Activation Molecule Family Member 1

Identifiers

PMID21667045
OpenAlexW2154206762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.